CVRx (CVRX) Income from Continuing Operations (2020 - 2026)
CVRx (CVRX) recorded quarterly Income from Continuing Operations of 13120000.0 in Q1 2026, down 9.77% quarter-over-quarter from 11952000.0 in Q4 2025, and up 4.69% on a YoY basis from 12531912.3 in Q1 2025.
CVRx (CVRX) Income from Continuing Operations (2020 - 2026) Analysis & Trends
CVRx's Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 13120000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 4.69% year-over-year to 13120000.0; the TTM figure through Mar 2026 stood at 52678000.0 (down 2.2% YoY), while the FY2025 annual figure was 53324000.0, up 11.07% from the prior year.
- Income from Continuing Operations was 13120000.0 for Q1 2026 at CVRx, down from 11952000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 9011000.0 in Q3 2023 to a low of 22186000.0 in Q1 2024.
- Historically, Income from Continuing Operations has averaged 12287588.24 across 5 years, with a median of 11651000.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations plunged 95.06% in 2024, then soared 37.95% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 10536000.0 in 2022, then rose by 14.43% to 9016000.0 in 2023, then retreated by 18.13% to 10651000.0 in 2024, then slipped by 12.21% to 11952000.0 in 2025, then declined by 9.77% to 13120000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 13120000.0 (Q1 2026), 11952000.0 (Q4 2025), and 12870000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | CVRx | 130.46 Mn | 58.16 Mn | 12.88 Mn | -13.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.12 Mn |
| Dec 31, 2025 | -11.95 Mn |
| Sep 30, 2025 | -12.87 Mn |
| Jun 30, 2025 | -14.74 Mn |
| Mar 31, 2025 | -13.77 Mn |
| Dec 31, 2024 | -10.65 Mn |
| Sep 30, 2024 | -13.10 Mn |
| Jun 30, 2024 | -14.03 Mn |
| Mar 31, 2024 | -22.19 Mn |
| Dec 31, 2023 | -9.02 Mn |
| Sep 30, 2023 | -9.01 Mn |
| Jun 30, 2023 | -11.65 Mn |
| Mar 31, 2023 | -11.37 Mn |
| Dec 31, 2022 | -10.54 Mn |
| Sep 30, 2022 | -9.83 Mn |
| Jun 30, 2022 | -11.07 Mn |
| Mar 31, 2022 | -9.99 Mn |
| Dec 31, 2021 | -10.57 Mn |
| Sep 30, 2021 | -6.13 Mn |
| Jun 30, 2021 | -17.75 Mn |